Exploring High Growth Canadian Tech Stocks In October 2024

In This Article:

The Canadian market has shown impressive resilience with a 1.4% rise in the last week and a substantial 28% increase over the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation, scalability, and adaptability to leverage these favorable conditions.

Top 10 High Growth Tech Companies In Canada

Name

Revenue Growth

Earnings Growth

Growth Rating

Docebo

14.54%

34.05%

★★★★★☆

Constellation Software

16.17%

23.55%

★★★★★☆

Wishpond Technologies

12.29%

118.36%

★★★★☆☆

HIVE Digital Technologies

49.31%

94.00%

★★★★★☆

GameSquare Holdings

38.08%

86.64%

★★★★★☆

Medicenna Therapeutics

62.37%

57.20%

★★★★★☆

Sabio Holdings

12.97%

122.50%

★★★★☆☆

Blackline Safety

22.29%

121.23%

★★★★★☆

BlackBerry

21.68%

81.78%

★★★★★☆

Sernova

78.22%

74.04%

★★★★★☆

Click here to see the full list of 21 stocks from our TSX High Growth Tech and AI Stocks screener.

We'll examine a selection from our screener results.

Constellation Software

Simply Wall St Growth Rating: ★★★★★☆

Overview: Constellation Software Inc., along with its subsidiaries, focuses on acquiring, building, and managing vertical market software businesses across Canada, the United States, Europe, and internationally, with a market capitalization of CA$93.90 billion.

Operations: With a market cap of CA$93.90 billion, Constellation Software Inc. generates revenue primarily from its Software & Programming segment, amounting to $9.27 billion. The company specializes in acquiring and managing vertical market software businesses globally.

Constellation Software's recent financial performance underscores its robust position in the tech sector, with a significant revenue increase to USD 2.47 billion and net income rising to USD 177 million in Q2 2024, reflecting year-over-year growths of 21% and 72%, respectively. This growth trajectory is complemented by a strong R&D focus, crucial for sustaining innovation and competitiveness; however, specific R&D spending figures remain undisclosed. Looking ahead, earnings are expected to surge by an impressive 23.6% annually over the next three years, outpacing the Canadian market's forecast of 15.7%. Despite these promising indicators, potential investors should note the company's high debt levels which could impact future financial flexibility.

TSX:CSU Earnings and Revenue Growth as at Oct 2024
TSX:CSU Earnings and Revenue Growth as at Oct 2024

Docebo

Simply Wall St Growth Rating: ★★★★★☆


  • <nobr id="awira"></nobr>